6.29 USD
↗ 0.06 (0.96%)AT CLOSE (11:59 AM EDT)
Gyre Therapeutics, Inc. Common Stock
GYRENASDAQ • USD
6.34
↗ 0.05 (0.81%)
POST MARKET (AS OF 07:57 PM EDT)
Post Market
AS OF 07:57 PM EDT
6.34
↗ 0.05 (0.81%)
Market: CLOSED
Shares of Gyre Therapeutics, Inc. Common Stock (GYRE) are trading at $6.29. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On valuation, GYRE trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 26, 2026.
Open?$6.28
High?$6.49
Low?$6.23
Prev. Close?$6.23
Volume?854.1K
Avg. Volume?121.0K
VWAP?$6.32
Rel. Volume?7.06x
Bid / Ask
Bid?$6.30 × 100
Ask?$6.33 × 700
Spread?$0.03
Midpoint?$6.31
Valuation & Ratios
Market Cap?701.3M
Shares Out?97.0M
Float?17.8M
Float %?18.4%
P/E Ratio?N/A
P/B Ratio?6.92
EPS?-$0.06
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases. The company's commercial-stage products include ETUARY, Avatrombopag, and Nintedanib. In addition, it is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis (MASH fibrosis). Gyre is also advancing a diverse pipeline of different drug candidates in China, including F573, F528, and F230. The company's reportable segments are Gyre Pharmaceuticals, which derives maximum revenue from the sale of ETUARY and certain generic drugs in the PRC, Gyre, and Other.
Employees
618
Market Cap
694.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-10-31
Address
12730 HIGH BLUFF DRIVE
SAN DIEGO, CA 92130
Phone: (858) 284-0115
SAN DIEGO, CA 92130
Phone: (858) 284-0115
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?100
Momentum?20
Short Sent.?48
Piotroski F-Score?2/9Weak
Altman Z-Score?17.39Safe
Confidence?51%Low
Short InterestVery High
Short % of Float?9.76%Elevated
Short Interest?1.7M
Days to Cover?18.4
Free Float17.8M
Avg Daily Volume94.4K
Settlement Date2026-06-15
Financial Health
Current Ratio?4.64Strong
Quick Ratio?4.06Strong
Cash Ratio?1.90Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score53/100
P/E?N/A▾
P/B?6.92FAIR▾
Peers100
S&P27
P/S?5.99FAIR▾
Peers100
S&P22
P/FCF?228.2PRICEY▾
Peers100
S&P3
EV/EBITDA?263.4HIGH▾
Peers100
S&P3
EV/Sales?5.67FAIR▾
Peers100
S&P30
Returns & Efficiency
ROE?-6.3%WEAK▾
S&P10
ROA?-3.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$3.1M
Enterprise Value?$663.8M
Fundamentals ratios updated end of day